PLoS ONE (Jan 2017)

In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery.

  • Daniel Tsung-Ning Huang,
  • Chun-Yi Lu,
  • Pei-Lan Shao,
  • Luan-Yin Chang,
  • Jin-Yuan Wang,
  • Yi-Hsuan Chang,
  • Mei-Ju Lai,
  • Ya-Hui Chi,
  • Li-Min Huang

DOI
https://doi.org/10.1371/journal.pone.0174523
Journal volume & issue
Vol. 12, no. 4
p. e0174523

Abstract

Read online

Influenza virus infection is a major threat to human health. Small interfering RNA (siRNA) is a promising approach for the prevention and treatment of viral infections. In this study, we constructed a series of DNA vector-based short hairpin RNAs (shRNAs) that target various genes of the influenza A virus using the polymerase III U6-RNA promoter to prevent influenza virus infection in vitro and in a mouse model.Three sets of DNA vector-based shRNA, two targeting genes encoding the polymerase acidic protein (PA) and one targeting polymerase basic protein 2 (PB2), efficiently inhibited the replication of influenza virus A/WSN/33(H1N1) in vitro. We also successfully prevented influenza virus A/WSN/33(H1N1) infection in a C57BL/6 mouse model by intratracheal delivery of anti-PB2 shRNA.Our findings suggest that the PB2-targeting shRNA plasmid showed potential for use as an RNAi-based therapeutic for influenza virus infection.